Salmonella group C necrotizing fasciitis: a case report and review of the literature

Localized salmonella soft tissue infections have been rarely described in humans. We report a case of necrotizing fasciitis caused by Salmonella serogroup C in a patient with systemic lupus erythematosus who was successfully treated with surgical debridement and cefoperazone–sulbactam. In addition,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diagnostic microbiology and infectious disease 2006-04, Vol.54 (4), p.319-322
Hauptverfasser:	Khawcharoenporn, Thana, Apisarnthanarak, Anucha, Kiratisin, Pattarachai, Mundy, Linda M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anti-Bacterial Agents - therapeutic use Bacterial diseases Bacterial diseases of the digestive system and abdomen Bacteriology Biological and medical sciences Cefoperazone - therapeutic use Child, Preschool Combined Modality Therapy Diagnosis, Differential Fasciitis, Necrotizing - diagnosis Fasciitis, Necrotizing - drug therapy Fasciitis, Necrotizing - microbiology Female Fundamental and applied biological sciences. Psychology Human bacterial diseases Humans Infection Infectious diseases Lupus Erythematosus, Systemic - complications Lupus Erythematosus, Systemic - diagnosis Lupus Erythematosus, Systemic - microbiology Male Medical sciences Microbiology Miscellaneous Necrotizing fasciitis Risk Factors Salmonella Salmonella - isolation & purification Salmonella Infections - diagnosis Salmonella Infections - drug therapy Salmonella Infections - epidemiology Salmonellosis Sulbactam - therapeutic use Systemic lupus erythematosus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Localized salmonella soft tissue infections have been rarely described in humans. We report a case of necrotizing fasciitis caused by Salmonella serogroup C in a patient with systemic lupus erythematosus who was successfully treated with surgical debridement and cefoperazone–sulbactam. In addition, we provide a literature review on risk factors and treatment of this uncommon disease sequelae.
ISSN:	0732-8893 1879-0070
DOI:	10.1016/j.diagmicrobio.2005.10.015